[WEBINAR] Trends in Peptides and Oligonucleotides – Choosing a Bartner CDMO
This webinar which will take you through the foreseeable future of peptides and oligonucleotides.
02.01.22
Date: Thursday,
February 24th
Time: 4:30pm UK /
5:30pm Switzerland /
8:30am PST
Peptide and
oligonucleotide
drugs are versatile
therapeutics with a
growing range of
applications and
many similarities in
terms of
manufacturing and
regulation. New
formulations often
increase the
complexity of the
products and demand
innovative
solutions.
Partnering with an
experienced CDMO can
support drug
developers’
manufacturing needs
and allow them to
focus on the core of
their
developments.
Please join our
webinar which will
take you through the
foreseeable future
of peptides and
oligonucleotides.
Tycho Leifels,
Ph.D. - Group
Leader Product
Management at
Bachem
li>
Daniel Grotzky,
Ph.D. - Head of
Group Communication
at
Bachem
li>
The Swiss based Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
Bachem is participating in this global event and invite you to be inspired by their innovative and sustainable approaches to generic API manufacturing.